about
Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brainsThe activation of cannabinoid CB2 receptors stimulates in situ and in vitro beta-amyloid removal by human macrophagesPharmacological and biochemical interactions between opioids and cannabinoids.A restricted population of CB1 cannabinoid receptors with neuroprotective activityThe CB(2) cannabinoid receptor controls myeloid progenitor trafficking: involvement in the pathogenesis of an animal model of multiple sclerosis.Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: role of 5HT(1A) and CB2 receptors.The endogenous cannabinoid system and the basal ganglia. biochemical, pharmacological, and therapeutic aspects.Endocannabinoids regulate the activity of astrocytic hemichannels and the microglial response against an injury: In vivo studies.Role of the endocannabinoid system in Alzheimer's disease: new perspectives.Cannabinoid CB1 receptors are expressed by parietal cells of the human gastric mucosaCannabinoid CB2 receptor: a new target for controlling neural cell survival?The seek of neuroprotection: introducing cannabinoids.The endocannabinoid system in neuropathological states.Endocannabinoids and Neurodegenerative Disorders: Parkinson's Disease, Huntington's Chorea, Alzheimer's Disease, and Others.Endocannabinoid regulation of amyloid-induced neuroinflammation.Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study.The activation of cannabinoid receptors in striatonigral GABAergic neurons inhibited GABA uptake.Loss of cannabinoid receptor binding and messenger RNA levels and cannabinoid agonist-stimulated [35S]guanylyl-5'O-(thio)-triphosphate binding in the basal ganglia of aged rats.Perinatal delta9-tetrahydrocannabinol exposure augmented the magnitude of motor inhibition caused by GABA(B), but not GABA(A), receptor agonists in adult rats.Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease.The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB(2) and adenosine receptors.Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity.Blockade of cannabinoid CB(1) receptor function protects against in vivo disseminating brain damage following NMDA-induced excitotoxicity.Circulating endogenous cannabinoid anandamide and portal, systemic and renal hemodynamics in cirrhosis.A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis.Neuroprotective effects of the nonpsychoactive cannabinoid cannabidiol in hypoxic-ischemic newborn piglets.Localization of mRNA expression and activation of signal transduction mechanisms for cannabinoid receptor in rat brain during fetal development.Autoradiographic analysis of cannabinoid receptor binding and cannabinoid agonist-stimulated [35S]GTP gamma S binding in morphine-dependent mice.The cannabinoid agonist WIN55212 reduces brain damage in an in vivo model of hypoxic-ischemic encephalopathy in newborn rats.Cannabinoid CB2 receptors in the mouse brain: relevance for Alzheimer's disease.Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous systemRole of the superior colliculus in the motor effects of cannabinoids and dopamineEnhancement of Anandamide Formation in the Limbic Forebrain and Reduction of Endocannabinoid Contents in the Striatum of Δ9-Tetrahydrocannabinol-Tolerant RatsExtrapyramidal effects of methanandamide, an analog of anandamide, the endogenous CB1 receptor ligandChanges in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinolThe endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neuronsInvolvement of GABA(B) receptors in the motor inhibition produced by agonists of brain cannabinoid receptorsActivational role of cannabinoids on movementColocalization of CB1 receptors with L1 and GAP-43 in forebrain white matter regions during fetal rat brain development: evidence for a role of these receptors in axonal growth and guidanceEndocannabinoid-hydrolysing enzymes in the post-mortem cerebellum of humans affected by hereditary autosomal dominant ataxias
P50
Q28189423-E4AFD74B-3982-4296-804D-16C281F05BE3Q28247725-79635E39-1DFF-4805-B99A-A88D14E09774Q33677066-1D4E92CC-12A4-4C27-A903-B1E4B5D512EEQ33730578-63911DAB-365F-4BCF-9B9D-497DC9958F36Q34589360-AA655EDD-EEA1-4328-BAF2-62C32BDF79E5Q34650465-E8237A94-00F5-4FED-8A75-EC6E716C7A48Q34786832-B4DB67AD-1242-4FB6-93C7-FA9EC879C554Q35616134-02C369F4-5819-4564-9C37-CD7E7E28BDE4Q35860973-A54AF458-79B0-45D0-99A0-49DCE6A03497Q36572905-E19D2CAB-4ADF-41CE-83A4-5D29913CAB92Q36671508-BB3E385D-FBE4-4612-A2CF-88B4979C4D32Q37067463-1DEC5CEF-0884-4A4B-8AF8-40C44CF874CAQ37444824-4E140614-C0A1-4F3B-B14E-AA78DCA360D5Q38593124-24EB1019-7773-4FAF-B079-E5C4B9FA69C1Q40546985-1B605EFC-8102-4627-ACDB-42FDD789D2DDQ41906876-F615360E-48E3-44E3-BE95-CE935E137B65Q42450193-60E8944C-E312-49D9-9DF8-CA794C6015CFQ42454808-1EF0E44B-93E9-49C0-8CB8-9A0DD978ED1AQ42474019-7423FF4A-678A-4254-98E6-DEB29B1C4140Q42478056-CF09FCE9-74C5-425C-9A80-AA0D5D318A84Q43245497-2DF6EE99-357D-4517-A12E-929DC5D8AE91Q43266820-88F752B4-E041-49B7-9D8A-804A3555E6E5Q44046073-45F61842-2452-4BA9-8308-20EE0BEE95A6Q45105185-95C1C972-0958-4C0D-97AF-3B4C0C29B603Q45501093-64DD5385-F952-4A1A-88AA-A66BE8892D3AQ46446532-6B97A531-27A0-401A-A4AF-C230FD22CE65Q47812684-CB7C19F4-8635-46D0-861D-44F898E1334FQ47897399-73A5F556-7FC1-4E0A-ABBA-5D6B4C7DDC42Q48109516-C46C96F3-7720-4E85-A81F-329E7CD1A582Q55078779-84292711-21D1-462A-B3B5-3A3AD43DC085Q57168673-CBD4EE0A-68A9-44E3-BFD9-73E1945B06BDQ60155183-BB14A0B4-1824-4DDC-B5A6-419BB1BA05F2Q60690625-7E70ECA3-56CB-4D90-8A79-915074817D12Q71040771-4EE72211-20A1-48BF-823A-DE8196AB856AQ72061444-F3696D9B-EAE8-4142-8299-2889B36456EEQ72302141-281E2876-C3DF-477D-8343-2BFF8B0DF63BQ73554044-BABDDADA-6EA0-482F-9228-145CBCB8942EQ73575705-FBAF7CAE-9173-4D00-BD6C-7C4E637128C9Q81050218-0689AD98-076B-4265-A8A5-22C920758D25Q87467512-73A7D09B-DD79-434D-85A5-6138481D87DD
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
研究者
@zh
name
Julian Romero
@ast
Julian Romero
@en
Julian Romero
@es
Julian Romero
@nl
type
label
Julian Romero
@ast
Julian Romero
@en
Julian Romero
@es
Julian Romero
@nl
altLabel
JULIAN ROMERO
@en
prefLabel
Julian Romero
@ast
Julian Romero
@en
Julian Romero
@es
Julian Romero
@nl
P106
P31
P496
0000-0002-2897-606X